The Healthy Family Program (NCT06427096) was a multicentre, open-label, cluster-randomised controlled trial conducted in rural China (80 clusters; n=8,001) assessing the effectiveness of a family-centred, community-based BP-lowering intervention. “It is important to reduce cardiovascular risk among individuals with high-normal BP, since the increase in risk often begins in this group,” explained Prof. Jun Cai (Beijing Anzhen Hospital, China) [1].
Eligible villages had at least 200 permanent households, with families comprising at least 2 members, and individuals aged 40–80 years, regardless of BP levels or antihypertensive treatment. The intervention included the formation of a BP management team comprising family leaders, village leaders, and village doctors, along with regular BP monitoring using a structured algorithm. Additional components included educational sessions promoting healthy lifestyles, distribution of low-sodium cooking salt, organised physical exercise sessions, and antihypertensive medication for eligible participants. The primary endpoint was systolic BP at 6 months of follow-up. Participants in the control group received usual care without these interventions.
At 6 months, the mean systolic BP decreased by 6.1 mmHg in the intervention arm but increased by 5.1 mmHg in the control arm (delta -10.7; 95% CI -11.8 to -9.6), indicating a clear benefit of the intervention. Other BP outcomes, including diastolic BP and antihypertensive treatment rates, also favoured the intervention. “The effect was particularly pronounced in participants aged >65 years, those with a history of hypertension, or baseline systolic BP ≥140 mmHg or a diastolic BP ≥90 mmHg,” noted Prof. Cai.
“The study showed that the Healthy Family Program effectively reduces BP in a broad population of patients,” Prof. Cai concluded. “At a cost of approximately $30 per person, it represents an affordable and scalable strategy. Considering that a 5 mmHg reduction in BP is associated with a 10% reduction in major cardiovascular events, these findings have substantial public health implications.”
- Cai J, et al. A family health instructor-led multifaceted intervention for blood pressure management in rural China: an open-label, cluster randomized trial (Healthy Family Program). AHA scientific sessions 2025, 7-10 November, New Orleans, LA, USA.
Posted on
Previous Article
« Is anticoagulation really needed after successful AF ablation? Next Article
Innovative strategy reduces BP in low-resource areas »
« Is anticoagulation really needed after successful AF ablation? Next Article
Innovative strategy reduces BP in low-resource areas »
Table of Contents: AHA 2025
Featured articles
Clear winner in post-PCI head-to-head trial
New subcutaneous drug improves outcomes in STEMI patients
Blood Pressure Control
Innovative strategy reduces BP in low-resource areas
Interesting family-based approach to lower BP
Valvular Heart Disease and Hypertrophic Cardiomyopathy
New treatment strategy saves lives in aortic stenosis
Innovative CABG procedure reduces morbidity in a specific population
Cardiometabolic Risk Mitigation
Pharmacological intervention tested in cardiac allograft vasculopathy
Clear-cut results from a large PCSK9 inhibition trial in high-risk ASCVD
Highly promising one-time treatment for hyperlipidaemia
New hypertriglyceridemia drug prevents dangerous condition
First-in-class therapeutic yields remarkable improvements in hypertriglyceridemia
Heart Failure Treatment Strategies
Is the new ‘super-pill’ for HF ready for prime time?
GLP-1 receptor agonists go head-to-head
Coronary Artery Disease
Clear winner in post-PCI head-to-head trial
New subcutaneous drug improves outcomes in STEMI patients
Atrial Fibrillation
Is anticoagulation really needed after successful AF ablation?
Counterintuitive result for coffee consumption in AF patients
Mono- or dual antithrombotic therapy beyond 1-year post-PCI in AF patients?
Can we reduce AF recurrence after ablation?
Innovative method to manage high-risk AF under investigation
Encouraging results from a novel antithrombotic strategy in AF after PCI
Related Articles
July 2, 2021
Ultra-processed food intake associated with IBD
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com
